Quotient Sciences Uses AI Algorithm to Select Modi...
Category : Clinical Trial Update 18 September 2026AI Algorithm Reaches Pharmacokinetic Target Within Three Dosing Periods Quotient Sciences has rep...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Biogen Publishes Adolescent Data From Phase 3 VALI...
Category : Clinical Trial Update 18 September 2026Study Results Show Reduced Proteinuria in Adolescents With Rare Kidney Diseases Biogen Inc. has a...
Sanofi and Cheplapharm Plan Strategic Partnership...
Category : Licensing/Collaboration Deal 17 September 2026Cheplapharm to Take Over Selected Medicines and Three Manufacturing Sites Sanofi and Cheplapharm...
Gland Pharma Plans to Make Gland Pharma USA a Dire...
Category : Merger/Acquisition 17 September 2026Board Approves Acquisition of Gland Pharma USA Gland Pharma Limited has announced that its board...
FDA Accepts Takeda’s Zasocitinib Application for M...
Category : Clinical Trial Update 17 September 2026FDA Grants Priority Review to Takeda’s Zasocitinib Application Takeda has announced that th...
Latest Newsletter Post
-
Biogen Publishes Adolescent Data Fr..
18 September 2026
-
Quotient Sciences Uses AI Algorithm..
18 September 2026
-
FDA Accepts Takeda’s Zasocitinib Ap..
17 September 2026
-
Gland Pharma Plans to Make Gland Ph..
17 September 2026
-
Sanofi and Cheplapharm Plan Strateg..
17 September 2026
